Bukwang Pharmaceutical Co., Ltd. (003000.KS)

KRW 4745.0

(-1.35%)

Total Debt Summary of Bukwang Pharmaceutical Co., Ltd.

  • Bukwang Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 79.38 Billion KRW , up 8428.99% from previous year.
  • Bukwang Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 79.56 Billion KRW , up 0.22% from previous quarter.
  • Bukwang Pharmaceutical Co., Ltd. reported annual total debt of 930.78 Million KRW in 2022, down -40.27% from previous year.
  • Bukwang Pharmaceutical Co., Ltd. reported annual total debt of 1.55 Billion KRW in 2021, down -92.77% from previous year.
  • Bukwang Pharmaceutical Co., Ltd. reported quarterly total debt of 79.56 Billion KRW for 2024 Q1, up 0.22% from previous quarter.
  • Bukwang Pharmaceutical Co., Ltd. reported quarterly total debt of 902.69 Million KRW for 2023 Q2, down -8.68% from previous quarter.

Annual Total Debt Chart of Bukwang Pharmaceutical Co., Ltd. (2023 - 2006)

Historical Annual Total Debt of Bukwang Pharmaceutical Co., Ltd. (2023 - 2006)

Year Total Debt Total Debt Growth
2023 79.38 Billion KRW 8428.99%
2022 930.78 Million KRW -40.27%
2021 1.55 Billion KRW -92.77%
2020 21.54 Billion KRW 936.93%
2019 2.07 Billion KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW 0.0%
2013 - KRW -100.0%
2012 20 Billion KRW -50.0%
2011 40 Billion KRW 100.0%
2010 20 Billion KRW -33.33%
2009 30 Billion KRW 0.0%
2008 30 Billion KRW 0.0%
2007 - KRW 0.0%
2006 - KRW 0.0%

Peer Total Debt Comparison of Bukwang Pharmaceutical Co., Ltd.

Name Total Debt Total Debt Difference
Dongwha Pharm.Co.,Ltd 48.25 Billion KRW -64.514%
Yuhan Corporation 230.07 Billion KRW 65.495%
Yuhan Corporation 230.07 Billion KRW 65.495%
Yuyu Pharma, Inc. 39.4 Billion KRW -101.453%
Yuyu Pharma, Inc. 39.4 Billion KRW -101.453%
Yuyu Pharma, Inc. 39.4 Billion KRW -101.453%
Ildong Holdings Co., Ltd. 382.06 Billion KRW 79.221%
Samil Pharmaceutical Co.,Ltd 175.87 Billion KRW 54.863%
Dong-A Socio Holdings Co., Ltd. 691.88 Billion KRW 88.526%
JW Pharmaceutical Corporation 170.28 Billion KRW 53.379%
JW Pharmaceutical Corporation 170.28 Billion KRW 53.379%
JW Pharmaceutical Corporation 170.28 Billion KRW 53.379%
SAMSUNG PHARM. Co., LTD. 595.48 Million KRW -13231.453%
Chong Kun Dang Holdings Corp. 468.03 Billion KRW 83.038%
Dong Sung Bio Pharm.Co.,Ltd. 43.27 Billion KRW -83.457%
HANDOK Inc. 300.01 Billion KRW 73.539%
Jeil Pharma Holdings Inc 173.03 Billion KRW 54.12%
Kukje Pharma Co., Ltd. 30.66 Billion KRW -158.909%
Aprogen pharmaceuticals,Inc. 180.99 Billion KRW 56.139%
Ilsung Pharmaceuticals Co., Ltd. 238.12 Million KRW -33238.192%
Daewon Pharmaceutical Co., Ltd. 146.04 Billion KRW 45.644%
Yungjin Pharm. Co., Ltd. 66.88 Billion KRW -18.697%
Boryung Corporation 204.21 Billion KRW 61.126%
Hyundai Pharmaceutical Co., Ltd. 39.2 Billion KRW -102.492%
Samjin Pharmaceuticals Co., Ltd. 118.63 Billion KRW 33.085%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW 6.779%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW 6.779%
Suheung Co., Ltd. 467.85 Billion KRW 83.032%
Kwang Dong Pharmaceutical Co., Ltd. 235.64 Billion KRW 66.31%
Hanall Biopharma Co.,Ltd 1.29 Billion KRW -6051.498%
Whan In Pharm Co.,Ltd. 632.02 Million KRW -12460.712%
MYUNGMOON Pharm co.,Ltd 90.48 Billion KRW 12.262%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -72.014%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -72.014%
Korea United Pharm Inc. 40.33 Billion KRW -96.799%
CKD Bio Corp. 146.92 Billion KRW 45.968%
Daewoong pharmaceutical Co.,Ltd 469.68 Billion KRW 83.098%
JW Holdings Corporation 554.58 Billion KRW 85.685%
REYON Pharmaceutical Co., Ltd. 225.05 Billion KRW 64.725%
Hanmi Pharm. Co., Ltd. 572.86 Billion KRW 86.142%
Dong-A ST Co., Ltd. 406.7 Billion KRW 80.48%
Chong Kun Dang Pharmaceutical Corp. 219.76 Billion KRW 63.876%
JW Lifescience Corporation 46.31 Billion KRW -71.415%
Ildong Pharmaceutical Co., Ltd. 217.84 Billion KRW 63.557%
Jeil Pharmaceutical Co.,Ltd 84.96 Billion KRW 6.566%
Hana Pharm Co., Ltd. 26.53 Billion KRW -199.2%